VANCOUVER Edition Citation

1.
, , , , . Prognostic impact of BTS (Baseline Tumor Size) on survival outcomes in patients with advanced Non-Small Cell Lung Cancer (NSCLC), treated with Pembrolizumab and Chemotherapy [Internet]. [Nantes]: Nantes Université; 2024. https://archive.bu.univ-nantes.fr/pollux/show/show?id=59a9a10f-33ed-4d8c-82ea-8dc2e4f2258c

ISO690 Edition Citation

, , , et . Prognostic impact of BTS (Baseline Tumor Size) on survival outcomes in patients with advanced Non-Small Cell Lung Cancer (NSCLC), treated with Pembrolizumab and Chemotherapy [en ligne]. Nantes : Nantes Université, 19 mai 2024. Disponible à l’adresse : https://archive.bu.univ-nantes.fr/pollux/show/show?id=59a9a10f-33ed-4d8c-82ea-8dc2e4f2258c

Style de citation APA (7e éd.)

Bellon Thibault, Liberge Renan, Frampas Éric, Blanc François-Xavier, & Pons-Tostivint Elvire. (2022). Prognostic impact of BTS (Baseline Tumor Size) on survival outcomes in patients with advanced Non-Small Cell Lung Cancer (NSCLC), treated with Pembrolizumab and Chemotherapy. Nantes Université.

Style de citation MLA (8e éd.)

Bellon Thibault, et al. Prognostic Impact of BTS (Baseline Tumor Size) on Survival Outcomes in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC), Treated with Pembrolizumab and Chemotherapy. Nantes Université, 2022.

Attention : ces citations peuvent ne pas être correctes à 100%.